Search Results

There are 20742 results for: content related to: Combination of a monoclonal anti-phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice

  1. You have full text access to this OnlineOpen article
    Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice

    International Journal of Cancer

    Volume 102, Issue 2, 10 November 2002, Pages: 101–108, Christiane J. Bruns, Marissa Shrader, Matthew T. Harbison, Charles Portera, Carmen C. Solorzano, K.-W. Jauch, Daniel J. Hicklin, Robert Radinsky and Lee M. Ellis

    Article first published online : 12 SEP 2002, DOI: 10.1002/ijc.10681

  2. You have open access to this content
    RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells

    Journal of Cellular and Molecular Medicine

    Volume 12, Issue 6a, December 2008, Pages: 2334–2349, C. Yu, X. Zhang, G. Sun, X. Guo, H. Li, Y. You, J. L. Jacobs, K. Gardner, D. Yuan, Z. Xu, Q. Du, C. Dai, Z. Qian, K. Jiang, Y. Zhu, Q. Q. Li and Y. Miao

    Article first published online : 6 FEB 2008, DOI: 10.1111/j.1582-4934.2008.00257.x

  3. Genetic transfer of PNAS-4 induces apoptosis and enhances sensitivity to gemcitabine in lung cancer

    Cell Biology International

    Volume 33, Issue 3, March 2009, Pages: 276–282, Shengyan Hou, Zhiwei Zhao, Fei Yan, Xiancheng Chen, Hongxin Deng, Xiang Chen, Yongsheng Wang and Yuquan Wei

    Article first published online : 2 JAN 2013, DOI: 10.1016/j.cellbi.2008.11.014

  4. You have full text access to this OnlineOpen article
    Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells

    FEBS Journal

    Volume 279, Issue 7, April 2012, Pages: 1261–1273, Fu Li, Gang Hu, Zhenzhou Jiang, Jingjing Guo, Ke Wang, Kedong Ouyang, Danyi Wen, Minghua Zhu, Jiaxin Liang, Xiaoran Qin and Luyong Zhang

    Article first published online : 12 MAR 2012, DOI: 10.1111/j.1742-4658.2012.08521.x

  5. You have full text access to this OnlineOpen article
    1,25D3 Enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models

    Cancer

    Volume 116, Issue 13, 1 July 2010, Pages: 3294–3303, Yingyu Ma, Wei-Dong Yu, Donald L. Trump and Candace S. Johnson

    Article first published online : 13 APR 2010, DOI: 10.1002/cncr.25059

  6. Antitumour activity of sunitinib in combination with gemcitabine in experimental pancreatic cancer

    HPB

    Volume 13, Issue 9, September 2011, Pages: 597–604, Niranjan Awasthi, Margaret A. Schwarz and Roderich E. Schwarz

    Article first published online : 7 JUN 2011, DOI: 10.1111/j.1477-2574.2011.00333.x

  7. You have free access to this content
    Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review

    BJU International

    Volume 109, Issue 4, February 2012, Pages: 496–505, Mike D. Shelley, Gabriel Jones, Anne Cleves, Timothy J. Wilt, Malcolm D. Mason and Howard G. Kynaston

    Article first published online : 7 FEB 2012, DOI: 10.1111/j.1464-410X.2011.10880.x

  8. Intravesical gemcitabine for non-muscle invasive bladder cancer

    Intervention Review

    The Cochrane Library

    Gabriel Jones, Anne Cleves, Timothy J Wilt, Malcolm Mason, Howard G Kynaston and Mike Shelley

    Published Online : 18 JAN 2012, DOI: 10.1002/14651858.CD009294.pub2

  9. Meta-analysis of Phase III randomized trials of molecular targeted therapies for advanced pancreatic cancer

    HPB

    Volume 14, Issue 4, April 2012, Pages: 260–268, Karim M. Eltawil, Paul D. Renfrew and Michele Molinari

    Article first published online : 26 FEB 2012, DOI: 10.1111/j.1477-2574.2012.00441.x

  10. Targeting Inside-Out Phospholipids on Tumor Blood Vessels in Pancreatic Cancer

    Vascular-Targeted Therapies in Oncology

    Adam W. Beck, Rolf A. Brekken, Philip E. Thorpe, Pages: 179–194, 2006

    Published Online : 31 MAY 2006, DOI: 10.1002/0470035439.ch10

  11. You have open access to this content
    Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment

    Cancer Science

    Volume 101, Issue 4, April 2010, Pages: 882–888, Hidenori Ojima, Daitaro Yoshikawa, Yoshihiro Ino, Hiroko Shimizu, Masashi Miyamoto, Akiko Kokubu, Nobuyoshi Hiraoka, Noriaki Morofuji, Tadashi Kondo, Hiroaki Onaya, Takuji Okusaka, Kazuaki Shimada, Yoshihiro Sakamoto, Minoru Esaki, Satoshi Nara, Tomoo Kosuge, Setsuo Hirohashi, Yae Kanai and Tatsuhiro Shibata

    Article first published online : 8 DEC 2009, DOI: 10.1111/j.1349-7006.2009.01462.x

  12. You have open access to this content
    Combination of conditionally replicative adenovirus and standard chemotherapies shows synergistic antitumor effect in pancreatic cancer

    Cancer Science

    Volume 100, Issue 11, November 2009, Pages: 2181–2187, Amy R. Nelson, Julia Davydova, David T. Curiel and Masato Yamamoto

    Article first published online : 21 JUL 2009, DOI: 10.1111/j.1349-7006.2009.01289.x

  13. Concurrent inhibition of NF-κB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer

    Journal of Cellular Biochemistry

    Volume 110, Issue 1, 1 May 2010, Pages: 171–181, Shadan Ali, Sanjeev Banerjee, Jacqueline M. Schaffert, Bassel F. El-Rayes, Philip A. Philip and Fazlul H. Sarkar

    Article first published online : 8 MAR 2010, DOI: 10.1002/jcb.22523

  14. Growth inhibition of pancreatic cancer cells by Histone Deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivo

    Molecular Carcinogenesis

    Wenwen Chien, Dhong Hyun Lee, Yun Zheng, Peer Wuensche, Rosie Alvarez, Ding Ling Wen, Ahmed M. Aribi, Su Ming Thean, Ngan B. Doan, Jonathan W. Said and H. Phillip Koeffler

    Article first published online : 8 MAR 2013, DOI: 10.1002/mc.22024

  15. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer

    Intervention Review

    The Cochrane Library

    Desmond Yip, Christos Karapetis, Andrew Strickland, Christopher B Steer and David Goldstein

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD002093.pub3

  16. Gemcitabine for unresectable, locally advanced or metastatic bladder cancer

    Intervention Review

    The Cochrane Library

    Mike Shelley, Anne Cleves, Timothy J Wilt and Malcolm Mason

    Published Online : 13 APR 2011, DOI: 10.1002/14651858.CD008976.pub2

  17. Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma

    BJU International

    Volume 108, Issue 2, July 2011, Pages: 168–179, Michael D. Shelley, Anne Cleves, Timothy J. Wilt and Malcolm D. Mason

    Article first published online : 1 JUL 2011, DOI: 10.1111/j.1464-410X.2011.10341.x

  18. The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer

    Journal of Cellular Biochemistry

    Volume 113, Issue 3, March 2012, Pages: 784–791, Niranjan Awasthi, Peter L. Yen, Margaret A. Schwarz and Roderich E. Schwarz

    Article first published online : 20 JAN 2012, DOI: 10.1002/jcb.23405

  19. You have full text access to this OnlineOpen article
    Enhanced antitumoral activity of oncolytic herpes simplex virus with gemcitabine using colorectal tumor models

    International Journal of Cancer

    Volume 132, Issue 7, 1 April 2013, Pages: 1592–1601, Shinichi Esaki, Fumi Goshima, Hiroshi Kimura, Shingo Murakami and Yukihiro Nishiyama

    Article first published online : 26 SEP 2012, DOI: 10.1002/ijc.27823

  20. The impact of practice guidelines and funding policies on the use of new drugs in advanced non-small cell lung cancer

    Journal of Evaluation in Clinical Practice

    Volume 11, Issue 4, August 2005, Pages: 350–356, George Dranitsaris, William K. Evans, Debbie Milliken and Brent Zanke

    Article first published online : 11 JUL 2005, DOI: 10.1111/j.1365-2753.2005.00546.x